Abstract Medium molecular weight glycol chitosan conjugates have been prepared, linked by an amide bond to paramagnetic Gd(III), Ho(III) and Dy(III) macrocyclic complexes in which a trifluoromethyl reporter group is located 6.5 Å from the paramagnetic centre. The faster relaxation of the observed nucleus allows modified pulse sequences to be used with shorter acquisition times. The polydisperse materials have been characterised by gel permeation chromatography, revealing an average molecular weight on the order of 13,800 (Gd), 14,600 (Dy) and 16, 200 (Ho), consistent with the presence of 8.5, 9.5 and 13 complexes, respectively. The gadolinium conjugate was prepared for both a q = 1 monoamide tricarboxylate conjugate (r 1p 11.2 mM -1 s -1 , 310 K, 1.4 T) and a q = 0 triphosphinate system, and conventional contrast-enhanced proton MRI studies at 7 T were undertaken in mice bearing an HT-29 or an HCT-116 colorectal tumour xenograft (17 lmol/kg). Enhanced contrast was observed following injection in the tail vein in tumour tissue, with uptake also evident in the liver and kidney with a tumour-to-liver ratio of 2:1 at 13 min, and large amounts in the kidney and bladder consistent with predominant renal clearance. Parallel experiments observing the 19 F resonance in the holmium conjugate complex using a surface coil did not succeed owing to its high R 2 value (750 Hz, 7 T). However, the fluorine signal in the dysprosium triphosphinate chitosan conjugate [R 1 /R 2 = 0.6 and R 1 = 145 Hz (7 T)] was sharper and could be observed in vivo at -65.7 ppm, following intravenous tail vein injection of a dose of 34 lmol/kg.
Introduction
Fluorine magnetic resonance imaging (MRI) has been promoted as an alternative to proton MRI or magnetic resonance spectroscopic imaging, owing to the 100 % isotopic abundance of the 19 F nucleus, the high NMR sensitivity and near-zero background signal [1] [2] [3] [4] . Over the past 20 years, notwithstanding the use of dedicated imaging coils, such work has been limited to observation of probes with high spin-density, e.g. locally injected perfluoralkyl and perfluoro-crown ether suspensions. Overall, limited impact has occurred, and only sporadic applications have been reported [5] . Over the past 5 years, we have shown that improvements in sensitivity of between tenfold and 25-fold can be gained in 19 F MRI, by placing a reporter trifluoromethyl group between 4.5 and 7 Å from a paramagnetic centre, such as a lanthanide ion (in particular, the faster relaxing and shifting ions: Dy, Tb Ho, Er and Tm) [6] [7] [8] [9] [10] [11] . If the trifluoromethyl group is too close, line broadening is very severe; if it is too distant, the relaxation rate enhancement is very small. An alternative approach has been suggested using a proximate Fe 3? or Mn 2? centre, in the context of monitoring enzymatic transformations by 19 F NMR, although rate enhancements were rather lower than ideal in the cases cited [12] . For rates of longitudinal relaxation of between 50 and 250 Hz, much shorter acquisition times can be used, including the use of a 'zeroecho time' imaging pulse sequence [13, 14] . These approaches are generally applicable to any spin-nucleus, and require that the R 1 /R 2 ratio be as close as possible to unity and that R 2 is preferably no greater than 300-500 Hz. Otherwise, concomitant broadening of the signal inhibits observation in spectroscopy. In imaging, if R 2 becomes large, ''T 2 losses'' occur during acquisition, associated with the longer RF pulse required and the spatial encoding process, limiting any intrinsic sensitivity gains.
A further aspect of this approach to more practicable 19 F imaging is that the spin density should be maximised within the region of interest that is observed. The use of low molecular weight fluorine-labelled lanthanide complexes per se is constrained by their rapid rates of clearance following intravenous introduction into the body. With this in mind, we have set out to study medium molecular weight polydisperse conjugates, in which about 30 fluorine nuclei (i.e. ten CF 3 groups, on average) are linked to a biocompatible vector. Such an approach has one main benefit in that the material will tend to clear more slowly from the body, as diffusion into the extravascular space is retarded. Such behaviour will increase the opportunities for 19 F imaging of the probe location, prior to excretion. The use of a conjugate that is readily metabolised by the action of natural glycosidase enzymes was also considered to offer advantages in ensuring longer-term whole body clearance, as the lower molecular weight monomeric complexes are normally expected to clear rapidly via the renal or biliary routes.
In this work, monomeric CF 3 -labelled lanthanide complexes have been used as they are kinetically inert with respect to premature dissociation of the metal ion in vivo [15] [16] [17] . Complexes of monoamide tricarboxylate and triphosphinate derivatives of 1,4,7,10-tetraazacyclododecane have been used, as they have been shown to be resistant to acid-catalysed dissociation pathways [18] . Furthermore, the CF 3 group is engineered to be about 6-6.5 Å from the paramagnetic centre. At this distance and at a field of 7 T, this makes the complexes of terbium, dysprosium and holmium rational choices for exploration, as they possess R 1 values in the range 50-150 Hz under these conditions [8, 19] .
Chitosan is a linear polysaccharide composed of randomly distributed b-(1-4)-linked D-glucosamine and Nacetyl-D-glucosamine moieties. Importantly, it is non-toxic, biodegradable and tolerated well in vivo [20] . It is produced via the deacetylation of chitin and is a cheap and readily available high molecular weight vector for bioconjugation work. The aqueous solubility is enhanced in the simple derivative glycol chitosan; this is commercially available. The material is polydisperse and, in this work, it was hydrolysed by acid digestion for 24 h [20] [21] [22] 2 ] prepared as a control (Scheme 1). The corresponding gadolinium complexes serve as proton MRI contrast agents, catalysing the relaxation of the signal of bulk water, which is proximate. Proton MRI studies were undertaken first to define the location of the conjugate, and 19 F imaging studies were attempted thereafter, aided by knowledge of the tissue distribution of the conjugate.
Materials and methods

Gel permeation chromatography
Gel permeation chromatography (GPC) was undertaken at Smithers Rapra (Shawbury, UK), using a Viscotek model 301 TDA instrument with an associated pump, autosampler and refractive index detector (with differential pressure and light scattering). Agilent PL aquagel-OH guard plus 2 9 PL aquagel-OH MIXED-M, 30-cm, 8-lm columns were used with an eluent composed of 0.5 M NaNO 3 and 0.01 M NaH 2 PO 4 at pH 2 at a flow rate of 1.0 ml/min at 303 K. The GPC system was calibrated using pullulan polysaccharides and the data were analysed using Malvern/ Viscotek OmniSEC.
Mass spectrometry
Both standard and high-resolution electrospray mass spectrometry (MS) were performed with a Thermo Finnigan LTQ Fourier transform instrument, operating in positive or negative ion mode as stated, with methanol as the carrier solvent. Matrix-assisted laser desorption/ionisation mass spectra were recorded with an Applied Biosystems Voyager-DE STR instrument with methanol as the carrier solvent. Liquid chromatography-MS analyses were performed with a Waters system comprising a 3100 mass detector and a 2998 photodiode-array detector.
NMR spectroscopy 1 H, 13 H data, approximately 0.5-1.2 mM solutions of the Gd(III) complexes in non-deuterated water at neutral pH were used. The exact complex concentration was determined by the bulk magnetic susceptibility shift method using a Bruker Avance III spectrometer operating at 11.7 T. Other relaxation measurements were made at 1.4 T using a Bruker Minispec mQ 60 relaxometer, operating at 310 K. 17 O NMR measurements were recorded with a Bruker Avance III spectrometer (11.7 T) equipped with a 5-mm probe and a standard temperature-control unit. An 8 mM aqueous solution of the complex containing 2.0 % of the 17 O isotope (Cambridge Isotope Laboratories) was used. The observed transverse relaxation rates were calculated from the signal width at half height.
MRI studies
Imaging studies were conducted using a 7-T Varian Unity Inova microimaging/preclinical system equipped with broadband capability and actively shielded gradients. For the 19 F MRI studies, a purpose-built four-turn solenoid coil (20- Dialysis was performed with cellulose membrane dialysis tubing with a molecular weight cut-off of 550 (SigmaAldrich), Spectra/Por dialysis membranes with a molecular weight cut-off of 1,000 (Spectrum Laboratories) or Float-A-Lyzer G2 filters with a molecular weight cut-off of 5,000 (Spectrum Laboratories). All tubing was washed thoroughly with water, as per the manufacturer's advice. After addition of the complex to the tubing, the ends of the tubing were secured (clamps for the membranes, the screw tops provided for the filters), and the ensemble was submerged in stirring water (approximately 500 ml). The bulk water was exchanged four times over a 72-h period, to ensure a positive dialysis gradient was maintained. Filtering of the contents of the tubing and lyophilisation yielded the desired product.
Glycol chitosan was purchased from Sigma and purified by dialysis before use. After purification, the sample had a molecular weight of about 195,000 as revealed by GPC analysis; its solubilisation in water required sonication over a period of 2 h. The sample was modified to prepare a lower molecular weight polymer, by acidic digestion with 4 M HCl at 323 K over 24 h. After dialysis purification, the sample possessed an average molecular weight of 6,590 (vide infra) and exhibited higher water solubility compared with the parent system.
To a solution of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (500 mg, 0.97 mmol) and 2-chloro-N-(4-(ethoxycarbonyl)-2-trifluoromethylphenyl)-ethanamide (331 mg, 1.07 mmol) in dry CH 3 CN (20 ml) under argon were added K 2 CO 3 (161 mg, 1.17 mmol) and KI (5 mg, catalyst). The mixture was boiled under reflux for 24 h. After filtration, the residue was washed with CH 2 Cl 2 (2 9 30 ml) and solvent was removed under reduced pressure to yield a pale brown oil that was purified by column chromatography over silica gel (CH 2 Cl 2 to CH 2 Cl 2 /10 %EtOH). The resultant oil was purified by crystallisation from hot diethyl ether, yielding a white powder (597 mg, 78 %), melting point 458-459 K. R f = 0.6 (silica, dichloromethane/5 %EtOH). 1 The structure of the sodium complex of 10-[(2-4-ethoxycarbonyl-2-(trifluoromethyl)phenylamino)-2-oxoethyl]-1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane was confirmed by single-crystal X-ray diffraction study of the NaBr adduct (CCDC 945380).
The crystal grown from diethyl ether was mounted in inert oil and transferred to the cold gas stream of the diffractometer.
Crystal data: [C 38 Fig. 1) . The shortest intramolecular FÁÁÁNa distances for these sites are 6.054 (2) and 6.14 (2) Å . Given that the ionic radius for sodium in eight coordination is 1.32 Å (versus 1.21 Å for Ho 3? ), the slightly shorter distances here are in line with the measurements estimated by NMR analysis of the variation of the 19 F relaxation rate with the field, which gave the separation of the CF 3 group from the lanthanide ion as 6.3 (±0.2) Å [8] .
Preparation of partially hydrolysed glycol chitosan (molecular weight approximately 6,590) Glycol chitosan (1 g, Sigma) was dissolved in a solution of hydrochloric acid (75 ml, 4 M), and any insoluble material was manually removed from the solution. The solution was left stirring at 323 K for 24 h, and then dialysed (molecular weigh cut-off 12,000) against Purite water until the pH of the tube contents reached neutrality (2 days). Lyophilisation yielded a light off-white powder (560 mg). Anal. Found: C, 37.84 %; H, 6.92 %; N, 5.57 %. For GPC analysis, see Table 1 .
To a stirred suspension of [Ho.L 1 (H 2 O)] (260 mg, 345 mmol) in dry dimethylformamide (2.2 ml) under argon were added N-methylmorpholine (NMM; 57 ml, 518.0 mmol) and finally tetramethyluronium tetrafluoroborate (TBTU; 166 mg, 518.0 mmol). The solution was stirred for 30 min at room temperature, and an aqueous solution of glycol chitosan (molecular weight approximately 6,590) (40 mg in 0.4 ml of water) was added dropwise. The mixture was left stirring overnight at 313 K. The crude product was diluted with water and dialysed The complex [Dy.L 3 ] (157 mg, 0.184 mmol) was dissolved in anhydrous dimethylformamide (2 ml), to which NMM (30 ll, 0.276 mmol) and TBTU (89 mg, 0.276 mmol) were added. The mixture was stirred at room temperature for 30 min under argon, before glycol chitosan (20 mg, molecular weight approximately 6,500) dissolved in water (0.2 ml) was added. The mixture was left stirring at 313 K for a further 18 h, before the solution was diluted with water (10 ml) and dialysed against Purite water for 48 h (molecular weight cut-off of 1,000), with the bulk solvent water being refreshed periodically. The solvent was removed under reduced pressure, before the residue was dissolved in water and dialysed for a second time (molecular weight cut-off of 5,000). The solution was lyophilised to yield a white solid (48 mg). 19 [9, 10] . The lanthanide(III) complexes derived therefrom were purified by preparative-scale reversedphase high-performance liquid chromatography. High-resolution accurate MS confirmed the constitution of the complexes, with experimental isotope patterns showing good correlation to those calculated. The 19 F NMR spectrum (D 2 O, 295 K 9.4 T) revealed the presence of one major species (87 %) and six minor species in solution, consistent with the formation of one predominant stereoisomer, amongst the 32 NMR-distinguishable isomers that are theoretically possible in this system [18] .
A representative synthesis of the conjugate [Dy.L 3 -chitosan] is outlined in Scheme 2. The carboxylic acid group of [Dy.L 3 ] was converted to an active ester, by reaction with o-(benzotriazol-1-yl)-N,N,N 0 ,N 0 -tetramethyluronium tetrafluoroborate and NMM in dimethylformamide. After the mixture had been stirred for 1 h, to allow formation of the active ester, a concentrated aqueous solution of partially hydrolysed glycol chitosan (average molecular weight 6,590) was added and the mixture was stirred for a further 36 h. Purification of the conjugate was achieved by extensive dialysis to remove unreacted coupling reagents and excess complex.
To determine the average size and the mean number of complexes conjugated to chitosan, the complex was analysed by aqueous GPC (Table 1) . By comparing the molecular weights of the unreacted complex and glycol chitosan with the molecular weight of [Dy.L 3 -chitosan], we calculated that there are around 8.5 complexes bound to each molecule of glycol chitosan. As glycol chitosan is a polydisperse material, such values are averages for the whole system. Low solubility in water had been observed in preliminary work with chitosan conjugates derived from a higher molecular weight precursor, but no solubility issues were seen with the conjugate reported here at the concentrations used (up to 10 mM).
The 19 F NMR spectrum of [Dy.L 3 -chitosan] displayed one principal resonance (86 %), indicating equivalence of each complex in the conjugated adduct (Fig. 2) . The occurrence of one major resonance is required for in vivo applications to ensure that signal intensity is maximised. Relaxation rates were measured at 4.7 and 9.4 T ( [19] . The longitudinal relaxation rate, R 1 , is almost twice as large for the dysprosium system, coupled with a sizeable reduction in the transverse relaxation rate, R 2 , calculated from the linewidth. Each of these factors will serve to improve signal intensity, and the combination of the improvement in both relaxation rates suggested considerable scope for acquisition of an , which is typical of such a monoaqua [Gd.DO3A-monoamide] complex (where DO3A is 1,4,7- tricarboxymethyl-1,4,7,10-tetraazacyclododecane) [23] . In the glycol chitosan conjugate, [Gd.L 1 -chitosan], the relaxivity was 11.2 mM -1 s -1 . Such an enhancement is associated with slower rotation of the gadolinium complex, increasing the rotational correlation time s R , leading to a higher relaxivity [23] . In theory, the increased viscosity of the solution, due to the presence of the dissolved polymer, may also be responsible for the increased relaxivity as molecular tumbling is slowed down. To confirm whether the higher relaxivity of the conjugate was related to a change in solution viscosity or to the presence of the covalently linked macromolecule, a control experiment was performed. A solution containing the gadolinium complex and the precursor 6,600 molecular weight glycol chitosan was prepared and its relaxivity was measured at 60 MHz at 310 K. The value obtained was 4.79 mM
, which is very similar to that of the parent complex. Such behaviour shows that the observed increased relaxivity is caused by the presence in solution of the covalently bonded conjugate.
The gadolinium conjugate can be used as a conventional contrast agent in proton MRI by virtue of its ability to enhance the rate of relaxation of the bulk water protons. The relaxation behaviour was assessed and compared with the behaviour of the parent gadolinium complex. Variabletemperature 17 O NMR measurements for [Gd.L 1 (H 2 O)] were performed in 17 O-enriched water (Fig. 3 ) and the data were analysed using the standard Swift-Connick method [24] to obtain an estimate of the water exchange lifetime s M . The analysis gave a s M value of 0.92 ls at 298 K, similar to the values for related monoamide derivatives based on [Gd-DO3A] [23] .
The relaxivity profiles as a function of temperature and magnetic field allowed information to be deduced on the water exchange rate and various associated parameters used in the Solomon-Bloembergen-Morgan equations. Fitting was undertaken assuming the presence of one coordinated water molecule (q = 1), at a distance of 3.0 Å from the metal ion (r GdH ) and fixing the values for the distance of closest approach to the paramagnetic centre of the outer-sphere solvent molecules (a = 4.0 Å ) and for their diffusion coefficient (D = 2.24 and 3.10 cm 2 s -1 , at 298 and 310 K, respectively). The values of the main parameters that describe the proton relaxation behaviour of the complex are reported in Table 3 and are consistent with those expected for such low molecular weight monoaqua complexes, with an additional contribution modelled as two more distant (q 00 ) water molecules, located on average 4.4 Å from gadolinium. This analysis is not entirely rigorous and provides only an estimate of the magnitude of the contribution of second-sphere solvent molecules to the overall relaxivity of the complexes. Clearly, a number of water molecules at different distances from the metal ion and with different lifetimes all contribute together to the observed relaxivity. The contribution of this mechanism is equivalent to that of two water molecules at a distance of 4.4 Å from gadolinium or to that of a single molecule localised at about 3.9 Å [23] .
For the gadolinium conjugate, the relaxivity behaviour as a function of temperature and magnetic field was also measured (Fig. 4) . In the case of macromolecular conjugates, the analysis of NMRD profiles requires a different approach, since the presence of a relatively fast local rotation of the complex, compared with the slow motion of the macromolecule, needs to be considered. This can be done by incorporating the description of the rotational dynamics according to the 'model-free' Lipari-Szabo approach into the Solomon-Bloembergen-Morgan equations for the inner-sphere relaxation mechanism [25, 26] . This model allows the contribution of the global rotation of the whole paramagnetic system (s RG ) to be separated from the contribution of a faster local motion (s RL ) associated with free rotation of the complex via the pendant arm.
The correlation of the two types of motions is described by the parameter S 2 , whose value ranges between 0 (completely independent motion) and 1 (totally correlated motion). The fitting of the NMRD profiles with the LipariSzabo model is shown in Fig. 4 (centre) , and the resulting best-fit parameters are reported in Table 4 .
For the macromolecular conjugates, only the high-field region was analysed because of the inadequacy of the Solomon-Bloembergen-Morgan model to reproduce the low-field data when the tumbling motion is so long. The parameters D 2 and s V were treated simply as fitting parameters and do not have a precise physical meaning. The values of q, r GdH , and s M were assumed to be identical to those found for the parent gadolinium complex.
The results are consistent with the presence of a slow tumbling motion of the system, superimposed on fast local rotation of the gadolinium chelates [27, 28] . This is underlined by the low value of S 2 . Moreover, the relaxivity reaches a maximum at 30 MHz (typically found at 20 MHz for more 'rigid' systems) of 15.9 mM -s -1 at 310 K. This is probably a consequence of a relatively fast internal motion (0.49 ns) rather than the slow global rotation (6 ns). The relatively long residence lifetime of the inner-sphere water molecule limits the relaxivity of the slowly tumbling system. Indeed, the relaxivity increases significantly with temperature. A maximum value is reached around 315 K. A simple simulation revealed that the relaxivity would increase to 27 if s M were 20 ns at 298 K and 20 MHz.
MRI studies with the [Gd.L 1 (H 2 O)-chitosan] conjugate were performed using nude mice bearing an HT-29 colorectal tumour xenograft as an animal model, with the aim of assessing the distribution and the tumour uptake of the conjugate. The mice were anaesthetised with a mixture of oxygen/1-2 % isoflurane, they were placed in the magnetic resonance system and scout images were obtained. A dynamic contrast-enhanced MRI study was performed in a single 2-mm slice containing the tumour and with acquisition of a total of 100 images in a 10-min acquisition period. Five baseline 1 H magnetic resonance images were collected (30 s), after which 200 ll of a 2.5 mM solution of the gadolinium chitosan conjugate was administered by manual intravenous injection in the tail during the r 1p is the proton relaxivity, s M is the water exchange lifetime, s R is the rotational correlation time, s V is the correlation time for the zerofield-splitting modulation, D 2 is the mean-square zero-field-splitting energy, q 00 is the number of second-sphere water molecules, and r 00 is their distance from gadolinium. recording of the sixth image. Each mouse (approximately 30 g, n = 4) received a dose of 0.017 mmol/kg. An almost immediate contrast enhancement (less than 1 min) was observed after administration of the conjugate, both in the tumour and in the bladder (Fig. 5) . The compound was well tolerated by the mice. The tumour area was analysed to measure the mean signal intensity profile as a function of time (Fig. 6 ). Rapid and selective uptake of the conjugate was observed in the tumour, within the 10-min acquisition time. This behaviour is most probably related to an EPR effect (enhanced permeability and retention) that is characteristic of such medium molecular weight conjugates [23] . This leads to their selective accumulation in tumours through the increased fenestration of the blood vessels in the area and subsequent slower rates of clearance from the site. This represents a potential advantage of such conjugates compared with lower molecular weight gadolinium complexes, which in healthy animals are usually more rapidly excreted via the kidney or liver and accumulate in the bladder more quickly after administration.
The presence of the conjugate in the bladder and liver is consistent with both renal and biliary excretion, indicating that the conjugate is being eliminated from the body by each of the major pathways. The mean signal intensity reached a value of 1.22. Corresponding values obtained using the commercially available gadolinium contrast agent Prohance and in analogous experiments were in the range 1.20-1.28, although the latter contrast agent was administered at a higher dose, i.e. 0.1 mmol/kg against 0.017 mmol/kg for the gadolinium chitosan conjugate.
A similar scouting experiment was undertaken with [Gd.L 3 -chitosan] to track its uptake, this time examining s RG is the global rotation of the whole paramagnetic system, s RL is the local motion contribution, S 2 is the correlation between the global motion and the local motion, q is the number of inner-sphere water molecules, a is the Gd-H distance for the outer-sphere water molecules, and D is the relative diffusion coefficient a At 20 MHz /kg) ; the data shown represent the mean intensity averaged over four animals (± the standard error of the mean). Fluctuations in the mean signal reflect effects of uncompensated respiratory motion; however, the overall long-term signal trend is clear Fig. 7 Change in signal intensity in proton magnetic resonance images taken 13 min after tail vein injection of a 0.03 mmol/kg dose of [Gd.L mice (four) bearing a related HCT-116 colorectal tumour xenograft. Conventional dynamic gradient spin-echo magnetic resonance scans (6.66-s temporal resolution) were taken before (six scans) and after injection, over a 13-min period following a single tail-vein injection of a 0.03 mmol/kg dose of the conjugate. The data were analysed in terms of the change in intensity [precontrast vs. postcontrast (13 min)] in the tumour, kidney, liver, bladder and muscle (Fig. 7) . The changes in intensity for tumour to liver and tumour to muscle at this time point were 2:1 and 5:1, respectively, with again clear evidence for predominant renal clearance, with similar retention over this time interval in the tumour and liver tissues. 19 19 F magnetic resonance images in a period of 1 h. No fluorine signal was detected after administration of the conjugate, most likely due to the rather broad linewidth observed (750 Hz) that led to T 2 losses in signal acquisition and hence insufficient signal intensity for observation on the experimental timescale.
Preliminary imaging studies with [Dy.L 3 -chitosan] were conducted using a 3D gradient echo sequence (Fig. 8) with a four-turn solenoid coil (20-mm diameter, 20-mm coil length). The R 1 and R 2 values were estimated to be 145 and 270 Hz, respectively, leading to a calculated Ernst angle of 60.7°for a repetition rate, T R , of 25 ms. With a total scan duration of 131 s, good-quality images were acquired at a resolution of 1 9 1 9 1 mm 3 . Shorter echo times, T E (2.07 ms), were applied in order to minimise R 2 loss. The resulting mean signal-to-noise ratio from the 1 9 1 9 1 mm 3 volume element was calculated to be 9.1, which was a significant improvement on previously studied compounds when scaled for comparison (to take account of differences in the total examination time and concentration). These results were promising for further investigation, and in vivo experiments were undertaken.
Preliminary in vivo studies were conducted on SCID male mice (30 g) with HT-29 tumours. Measurements were taken 10-14 days after inoculation when the tumours were around 10 mm in diameter, with the mouse anaesthetised with a mixture of ketamine (0.75 mg/kg) and medetomidine (0.5-1.0 mg/kg). The mouse was positioned on an 19 F-tuned square surface coil (30-mm coil length) and the magnetic resonance system was calibrated using a reference vial placed between the mouse and the coil which was subsequently removed remotely without disturbing the mouse. A solution (5 mM) of [Dy.L 3 -chitosan] was then administered by intravenous injection in the tail. The mouse received 250 ll of the solution, corresponding to a Grid lines on the image indicate the equivalent location of each spectrum in the magnetic resonance spectroscopic imaging dataset dose of 0.037 mmol/kg. Immediately following injection, simple detection of the [Dy.L 3 -chitosan] was confirmed using unlocalised spectroscopy, which demonstrated both the expected resonance and a second unidentified resonance shifted by -4,900 Hz (-17 ppm), which was not seen from the reference sample (Fig. 9) . The nature of this second species remains uncertain. Although the in vitro data (Fig. 8) could be collected using a standard imaging sequence, the linewidths in vivo were broader, and localised spectral detection was therefore applied using a 2D spectroscopic imaging approach, allowing much shorter T E and hence reduced R 2 -related signal loss. The distribution of the complex within the mouse was clearly mapped.
Conclusions
This proof-of principle study introduces the idea of a fastrelaxing fluorinated probe in a conjugate that clears relatively slowly from the body. These features allow 19 F chemical spectral imaging studies to be undertaken at doses that are in the range of those used in the clinically approved series of gadolinium contrast agents. There remains a need to understand better the origins of the line-broadening phenomenon observed in vivo, as this limits the resolution and sensitivity of the method, with the materials examined herein. A tentative suggestion is that there may be some non-covalent association in vivo with endogenous macromolecules, e.g. protein, that gives rise to some chemical exchange broadening.
The work has wider implications, as it demonstrates that a fast-relaxing spin label can be observed in vivo on timescales that are amenable to modern imaging methods. Such behaviour holds, provided that the label can be observed selectively in the appropriate spectral window. In the systems described here, the extension to gadoliniumenhanced imaging studies of the water signal is particularly useful, as it allows genuine dual imaging protocols to be developed, observing water and probe signals sequentially, simply by permuting the lanthanide ion in the same ligand or conjugate structure.
The extension of these ideas to the use of paramagnetically shifted proton spin labels ('PARASHIFT' proton magnetic resonance) is being reported concurrently [29] for related macrocyclic structures labelled with a tert-butyl reporter resonance that is around 6-7 Å from the paramagnetic centre.
